Integrating drug delivery principles into drug design to transform the treatment of immune disease

Porter, Christopher (Primary Chief Investigator (PCI))
Alderuccio, Frank (Chief Investigator (CI))
Charman, William (Chief Investigator (CI))
Trevaskis, Natalie (Chief Investigator (CI))

Project: Research

Status	Finished
Effective start/end date	1/01/11 → 30/12/14

Funding

National Health & Medical Research Council (NHMRC): AUD533,390.00
National Health & Medical Research Council (NHMRC)

Related content

Research Output

Profiling the role of deacylation-reacylation in the lymphatic transport of a triglyceride-mimetic prodrug

Research output: Contribution to journal › Article › Research › peer-review

From sewer to saviour-targeting the lymphatic system to promote drug exposure and activity

Research output: Contribution to journal › Article › Research › peer-review